ADVANCING IMMUNE-GENE THERAPY ACROSS DISEASES
The 6th edition of the ground-breaking series of ICLE Conferences will gather the brightest minds in lymphocyte engineering and redefine the boundaries of immune-gene and cell therapy. This is the place where you can uncover groundbreaking research, witness revolutionary clinical practices, and explore the future of treatment. ICLE is where immunotherapy converges with cell and gene therapy, sparking dynamic collaborations that amplify the synergy between basic and clinical research across diverse disease specialties.
Join us at the forefront of scientific innovation for a truly transformative experience and make your contribution to shaping the future of medical breakthroughs.
PROGRAM
Explore the cutting-edge sessions covering the most recent scientific advancements in lymphocyte engineering.
ABSTRACTS
Ensure your research gets the recognition it deserves at the the premier event in the field. Join the program in Milan!
REGISTRATION
Book your seat and join the ICLE community in Milan as we share, learn, and work together toward meaningful progress.
SPONSORSHIP
Showcase your innovative solutions, connect with industry leaders, and elevate your company’s visibility and growth.
Featured Speakers
Drew Weissman
University of Pennsylvania School of Medicine, USA
Carl June
Parker Institute Cancer Immunotherapy; University of Pennsylvania, USA
Jennifer Brogdon
Novartis Institutes for Biomedical Research, USA
Chiara Bonini
San Raffaele University, Italy
Stanley Riddell
Fred Hutchinson Cancer Center, USA
ICLE 2026 Committee
Adi Barzel
ICLE Conference Co-Chair
President of the Israeli Society for Gene and Cell Therapy (ISGCT), Senior lecturer at Tel-Aviv University
Israel
Dirk Busch
ICLE Conference Co-Chair
Director at the Institute for Med. Microbiology, Immunology and Hygiene Technical University of Munich
Germany
Chiara Bonini
ICLE Conference Co-Chair
Deputy Director, Division of Immunology, Transplantation and Infectious Diseases; Head, Experimental Haematology Unit; Vita-Salute San Raffaele University
Italy
Luigi Naldini
ICLE Conference Co-Chair
San Raffaele University School of Medicine and San Raffaele Telethon Institute for Gene Therapy
Italy
2025 Exhibitors & Sponsors
The ICLE Advantage - Enhance Your Future
Embark on a journey at the forefront of scientific exploration, where groundbreaking topics take center stage. This is the exclusive platform where leading minds unveil the latest breakthroughs, sharing insights that bridge the gap from research to clinical practice. Immerse yourself in invaluable discussions with top-notch experts in lymphocyte engineering therapies, gaining a firsthand understanding of the challenges and triumphs in the field.
REVOLUTIONARY TOPIC
The only international conference focusing specifically on research and clinical translation of gene therapy, cell therapy, genome engineering, and immunotherapy.
LATEST BREAKTHROUGHS
Learn what is done to translate the lymphocyte engineering research to clinical practice and how your colleagues overcome their challenges.
TOP-NOTCH EXPERTS
Hear from renown leaders, sharing invaluable insights on lymphocyte engineering therapies and discuss the latest findings and trends.
ESTABLISH COLLABORATIONS
ICLE's international community of scientists at the forefront of translational medicine is the place to be to create new successful partnerships.
AMPLIFIED EXPOSURE
Make your work visible, receive feedback, discuss your results with colleagues and experts from all over the world, and find future collaborators.
GREAT LOCATION
Home to a thriving biomedical innovation ecosystem and one of Europe’s most captivating destinations, Milan is an ideal backdrop for ICLE 2026.
ICLE 2026 is organized in collaboration with
SITGEC -
The Italian Society of Gene and Cell Therapy
